These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 198309)

  • 1. [Anti-foot-and-mouth vaccines combined with other bacterial or viral vaccines].
    Favre H; Valette L; Précausta P; Roulet C; Brun A; Terré J; Fontaine J; Stellmann C
    Dev Biol Stand; 1976; 35():409-28. PubMed ID: 198309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined vaccines including 1 or several anti-foot-and-mouth valences].
    Fontaine J; Favre H; Valette L; Précausta P; Roulet C; Brun A; Terré J
    Dev Biol Stand; 1976; 35():395-407. PubMed ID: 198308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary study of the combination of anti-foot-and-mouth disease and anti-brucellosis vaccines].
    Mastan MB; Amighi M; Ardelan A; Bandpay MR; Ebadi A; Farsi J
    Dev Biol Stand; 1976; 35():437-43. PubMed ID: 198311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency testing of foot--and--mouth disease vaccines prepared from strain "C" with different adjuvants.
    Sólyom F; Fazekas A; Czelleng F; Makár A; Roith J
    Dev Biol Stand; 1976; 35():113-5. PubMed ID: 198276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunization of ewes against experimental Brucella melitensis infection: comparison of eleven vaccines].
    Gaumont R; Trap D; Gayot G; Pierre F; Dhennin L
    Dev Biol Stand; 1976; 31():377-86. PubMed ID: 944151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the current status of oil adjuvants in foot--and--mouth disease vaccines.
    McKercher PD; Graves JH
    Dev Biol Stand; 1976; 35():107-12. PubMed ID: 198275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of animal rabies by an attenuated monovalent or mixed vaccine].
    Soulebot JP; Précausta P; Brun A; Chappuis G; Terré J; Favre H; Petermann HG
    Dev Biol Stand; 1978; 41():389-99. PubMed ID: 753667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of simultaneous inoculation of B. abortus strain 19 and foot-and-mouth disease vaccines on immunity against brucellosis in the guinea pig].
    García-Carrillo C
    Rev Asoc Argent Microbiol; 1978; 10(1):1-7. PubMed ID: 210482
    [No Abstract]   [Full Text] [Related]  

  • 9. [Production, control and use in swine of anti-foot-and-mouth disease vaccine in oil adjuvant].
    Chappuis G; Brun A; Roulet C; Favre H; Terré J
    Dev Biol Stand; 1976; 35():139-48. PubMed ID: 198280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: serologic tests.
    Jones LM; García-Carrillo C; Alton GG
    Am J Vet Res; 1973 Feb; 34(2):199-202. PubMed ID: 4631096
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined vaccination of cattle against FMD and rabies.
    Palanisamy R; Ramanna BC; Ananda Rao K; Srinivasan VA
    Microbiologica; 1992 Jan; 15(1):45-9. PubMed ID: 1313530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: pattern of immunoglobulin production after vaccination and challenge.
    Varela-Diaz VM; Jones LM; Perez-Esandi MV
    Am J Vet Res; 1973 Feb; 34(2):203-7. PubMed ID: 4631097
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methods of testing of safety of the anti-foot-and-mouth disease vaccine].
    Dannacher G; Fédida M; Coudert M; Perrin M
    Dev Biol Stand; 1976; 35():271-8. PubMed ID: 198294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
    Dénes B
    Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
    Bauer K
    Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intranasal vaccination of cattle against foot-and-mouth disease].
    Bauer K; Straub OC
    Berl Munch Tierarztl Wochenschr; 1985 Jul; 98(7):247-50. PubMed ID: 2994624
    [No Abstract]   [Full Text] [Related]  

  • 19. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.